Compared with the lowest quintile of midlife physical activity, the top two quintiles were associated with 40% lower all-cause dementia risk over 26 years (HR 0.60 for quintile 4, 95% CI 0.41-0.89; HR ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after ...

Alzheon, Inc., a clinical-stage biopharmaceutical company advancing innovative therapeutics and diagnostics for patients with Alzheimer’s disease (AD), today announced it will present new efficacy and ...

Staring at the ceiling while the clock blinks 3am doesn't only sap energy for the next day. A large, long-running U.S. study of older adults has now linked chronic insomnia to changes inside the brain ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference, being held in ...

NewAmsterdam Pharma gains from strong phase 3 obicetrapib results, LDL-C reduction and expansion into diabetes and ...

In 2025 your DNA decides what lands on your braai grid. Affordable gene tests and proudly South African fermented foods are ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®) at the Clinical Trials ...